TNFSF10 and neoplasm: When the particles were surface-coated with TRAIL for additional tumour targeting, the fluorescently labelled TRAIL was released from the particles more rapidly than the more deeply embedded doxorubicin, both in vitro and in vivo (Fig. 7C).